People with less body fat may reach peak levels and clear the drug somewhat faster, which can shift when between-dose symptoms show up
Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
Losing access to these medications was particularly frustrating when the results of not having them were so evident
However, patients with psychiatric disorders were often excluded from clinical trials, leaving safety and efficacy in this population largely unexplored
This strain has been shown to reduce symptoms in people with IBS especially bloating however, its effectiveness hasn't been replicated in those without IBS
The results of this study can be used for doctors clinical decision-making